{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T11:40:55Z","timestamp":1682854855281},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00579700","type":"journal-article","created":{"date-parts":[[2004,11,22]],"date-time":"2004-11-22T16:53:47Z","timestamp":1101142427000},"page":"149-154","source":"Crossref","is-referenced-by-count":1,"title":["A radioreceptor assay for TNF?-binding proteins"],"prefix":"10.1007","volume":"14","author":[{"given":"V.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Muirden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351008","volume":"35","author":"AP Cope","year":"1992","unstructured":"Cope AP, Aderka D, Doherty M et al (1992) Soluble tumour necrosis factor (TNF) receptors are increased in sera and synovial fluids of patients with rheumatic diseases. Arthritis Rheum 35:1160?1169","journal-title":"Arthritis Rheum"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780360408","volume":"36","author":"P Roux-Lombard","year":"1993","unstructured":"Roux-Lombard P, Punzi L, Hasler F et al (1993) Soluble tumour necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 36:485?489","journal-title":"Arthritis Rheum"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/31.5.293","volume":"31","author":"FM Brennan","year":"1992","unstructured":"Brennan FM, Maini RN, Feldmann M (1992) TNF-alpha?a pivotal role in rheumatoid arthritis? Br J Rheumalol 31:293?298","journal-title":"Br J Rheumalol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","volume":"36","author":"MJ Elliot","year":"1993","unstructured":"Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Chrayeb J, Wood JN (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF alpha. Arthritis Rheum 36:1681?1690","journal-title":"Arthritis Rheum"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1016\/S0021-9258(18)80162-4","volume":"264","author":"H Engelmann","year":"1989","unstructured":"Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D (1989) A tumour necrosis factor-binding protein purified to homogenity from human urine protects cells from tumour necrosis factor toxicity. J Biol Chem 264:11974?11950","journal-title":"J Biol Chem"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0609.1989.tb00111.x","volume":"42","author":"I Olsson","year":"1989","unstructured":"Olsson I, Lantz M, Nilsson E et al (1989) Isolation and characterisation of a tumour necrosis factor binding from urine. Eur J Haematol 42:270?275","journal-title":"Eur J Haematol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-1759(91)90150-E","volume":"141","author":"N-B Liabakk","year":"1991","unstructured":"Liabakk N-B, Sundan A, Waage A et al (1991) Development of immunoassays for the detection of soluble tumour necrosis factor receptors. J Immunol Methods 141:237?243","journal-title":"J Immunol Methods"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02172088","volume":"3","author":"I Olsson","year":"1991","unstructured":"Olsson I, Gullberg U, Lantz M, Peetre C (1991) A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF. Biotherapy 3:159?165","journal-title":"Biotherapy"},{"key":"CR9","unstructured":"Reference deleted"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1098\/rspb.1991.0096","volume":"245","author":"CD Hwang","year":"1991","unstructured":"Hwang CD, Gatanaga M, Innins EK, Yamamoto RS, Granger GA, Gatanaga T (1991) A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro. Proc R Soc Lond [Biol] 245:115?119","journal-title":"Proc R Soc Lond [Biol]"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08977199209011015","volume":"6","author":"NA Nicola","year":"1992","unstructured":"Nicola NA, Cary D (1992) Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors. Growth Factors 6:119?129","journal-title":"Growth Factors"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"16450","DOI":"10.1016\/S0021-9258(18)49277-0","volume":"262","author":"BB Aggarwal","year":"1987","unstructured":"Aggarwal BB, Eessalu TE (1987) Effects of phorbol esters on down regulation and redistribution of cell-surface receptors for tumour necrosis factor. J Biol Chem 262:16450?16455","journal-title":"J Biol Chem"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/infdis\/167.6.1344","volume":"167","author":"L Shapiro","year":"1993","unstructured":"Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA (1993) Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 167:1344?1350","journal-title":"J Infect Dis"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780360812","volume":"36","author":"D Aderka","year":"1993","unstructured":"Aderka D, Wysenbeek A, Engelmann H et al (1993) Correlation between serum levels of soluble tumour necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 36:1111?1120","journal-title":"Arthritis Rheum"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","volume":"36","author":"P Barrera","year":"1993","unstructured":"Barrera P, Boerbooms AMTh, Jansson EM et al (1993) Circulating soluble tumour necrosis factor receptors, interleukin-2 receptors, tumour necrosis factor alpha and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 36:1070?1079","journal-title":"Arthritis Rheum"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0896-8411(89)90129-7","volume":"2","author":"FM Brennan","year":"1989","unstructured":"Brennan FM, Chantry D, Jackson AM, Maini RN, Feldman M (1989) Cytokine production in culture by cells isolated from synovial membrane. J Autoimmun 2 [Suppl]:177?186","journal-title":"J Autoimmun"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/eji.1830211134","volume":"21","author":"W Lesslauer","year":"1991","unstructured":"Lesslauer W, Tabuchi H, Gentz R et al (1991) Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immuol 21:2883?2886","journal-title":"Eur J Immuol"},{"key":"CR18","first-page":"1335","volume":"142","author":"TR Ulich","year":"1993","unstructured":"Ulich TR, Yin S, Remick DG, Russell D, Eisenberg SP, Kohno T (1993) Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am J Pathol 142:1335?1338","journal-title":"Am J Pathol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","volume":"175","author":"D Aderka","year":"1992","unstructured":"Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D, (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323?329","journal-title":"J Exp Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780310816","volume":"31","author":"T Saxne","year":"1988","unstructured":"Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detecion of tumour necrosis factor alpha but not tumour necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041?1045","journal-title":"Arthritis Rheum"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0167-5699(90)90067-J","volume":"11","author":"K James","year":"1990","unstructured":"James K (1990) Interaction between cytokines and alpha-2-macroglobulin. Immunol Today 11:163?166","journal-title":"Immunol Today"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.4049\/jimmunol.150.11.5070","volume":"150","author":"Y Abe","year":"1993","unstructured":"Abe Y, Gatanaga M, Osuka Y et al (1993) Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol 150:5070?5079","journal-title":"J Immunol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","volume":"73","author":"DW Banner","year":"1993","unstructured":"Banner DW, D'Arcy A, Janes W et al (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431?445","journal-title":"Cell"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/abbi.1993.1040","volume":"300","author":"T Galeotti","year":"1993","unstructured":"Galeotti T, Boscoboinik D, Azzi A (1993) Regulation of the TNF-? receptor in human osteosarcoma cells: role of microtubules and of protein kinase C. Arch Biochem Biophys 300:287?292","journal-title":"Arch Biochem Biophys"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00579700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00579700\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00579700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T11:24:08Z","timestamp":1682853848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00579700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00579700"],"URL":"https:\/\/doi.org\/10.1007\/bf00579700","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}